Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brain effects of hormonal contraceptives
2023-507842-10-00Phase 4Completed
- Sponsor
- Region Uppsala
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in contraception comparing Estetrol + drospirenone with Ethinylestradiol + levonorgestrel (2 arms). Primary endpoint: Change in brain structure and function. Started Jan 2024; status: completed.
02
Drugs
estetrol + drospirenoneethinylestradiol + levonorgestrel
03
Conditions
contraception
Beyond the preview
Go deeper on 2023-507842-10-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-507842-10-00.